Target intelligence / Profile preview

Mitochondrial oxidative phosphorylation machinery (OXPHOS) (OXPHOS)

Target
OXPHOS
Molecular classification
Enzyme, Protein complex, Oxidoreductase, Transporter
01

Overview

The mitochondrial oxidative phosphorylation (OXPHOS) machinery in parasitic helminths is a vital system for energy generation, specifically adapted to the hypoxic environments of the host's body (Amino et al., 2005). While mammalian mitochondria primarily perform aerobic respiration, many helminths utilize a unique anaerobic pathway involving rhodoquinone and fumarate reductase (FRD) to maintain energy production (Kita et al., 2007). This specialized machinery, particularly Complex II acting as FRD, is a primary target for several classes of anthelmintic drugs (Mogi et al., 2009). For instance, salicylanilides like niclosamide act as uncouplers that dissipate the mitochondrial proton gradient, while other agents inhibit electron transport or specific enzymatic activities within the chain (Wojtkowiak et al., 2013). Because these anaerobic pathways are absent or significantly different in human hosts, they provide a high degree of selective toxicity. Disrupting the OXPHOS machinery leads to a rapid depletion of cellular ATP, resulting in the paralysis and eventual death of the parasite. Consequently, this system remains a cornerstone for developing treatments against various helminthic infections, including ascariasis and fascioliasis.

Other names
Mitochondrial respiratory chainElectron transport chainFumarate respiration systemHelminth mitochondrial respiratory system
02

Mechanism of action

Inhibition of fumarate reductase activity, uncoupling of oxidative phosphorylation by dissipating the mitochondrial proton gradient, and inhibition of electron transport through the respiratory chain complexes (Amino et al., 2005; Mogi et al., 2009).

03

Biological functions

ATP synthesisEnergy metabolismRedox homeostasisAnaerobic respiration
04

Disease associations

InfectionHelminthiasisAscariasisFascioliasisSchistosomiasisEchinococcosis
05

Safety considerations

Potential for mitochondrial toxicity in host cells due to off-target uncoupling (Wojtkowiak et al., 2013)Low systemic bioavailability of certain uncouplers limiting efficacy against tissue-dwelling parasitesDevelopment of drug resistance in both human and veterinary medicineNarrow therapeutic index for some uncoupling agents
06

Interacting drugs

Niclosamide

6 more in the full profile.

07

Biomarkers

Parasite egg reduction rate (ERR)Mitochondrial membrane potentialATP/ADP ratioSuccinate/fumarate ratio

Beyond the preview

Go deeper on Mitochondrial oxidative phosphorylation machinery (OXPHOS) (OXPHOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial oxidative phosphorylation machinery (OXPHOS) (OXPHOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call